[go: up one dir, main page]

NL970031I2 - Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative. - Google Patents

Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.

Info

Publication number
NL970031I2
NL970031I2 NL970031C NL970031C NL970031I2 NL 970031 I2 NL970031 I2 NL 970031I2 NL 970031 C NL970031 C NL 970031C NL 970031 C NL970031 C NL 970031C NL 970031 I2 NL970031 I2 NL 970031I2
Authority
NL
Netherlands
Prior art keywords
phthalan
preparation
derivative
derivatives
pharmaceutical preparations
Prior art date
Application number
NL970031C
Other languages
Dutch (nl)
Other versions
NL970031I1 (en
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9722860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL970031(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NL970031I1 publication Critical patent/NL970031I1/en
Publication of NL970031I2 publication Critical patent/NL970031I2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL970031C 1976-01-14 1997-08-04 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative. NL970031I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1486/76A GB1526331A (en) 1976-01-14 1976-01-14 Phthalanes

Publications (2)

Publication Number Publication Date
NL970031I1 NL970031I1 (en) 1997-10-01
NL970031I2 true NL970031I2 (en) 1997-10-01

Family

ID=9722860

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7700244A NL192451C (en) 1976-01-14 1977-01-12 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.
NL970031C NL970031I2 (en) 1976-01-14 1997-08-04 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL7700244A NL192451C (en) 1976-01-14 1977-01-12 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.

Country Status (19)

Country Link
US (1) US4136193A (en)
JP (1) JPS52105162A (en)
AT (1) AT359488B (en)
AU (1) AU509445B2 (en)
BE (1) BE850401A (en)
CA (1) CA1094087A (en)
CH (3) CH626886A5 (en)
DE (1) DE2657013C2 (en)
DK (1) DK143275C (en)
ES (1) ES454980A1 (en)
FI (1) FI63754C (en)
FR (1) FR2338271A1 (en)
GB (1) GB1526331A (en)
IE (1) IE44055B1 (en)
NL (2) NL192451C (en)
NO (2) NO147243C (en)
NZ (1) NZ183001A (en)
SE (1) SE429551B (en)
ZA (1) ZA7757B (en)

Families Citing this family (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602035A (en) * 1983-12-07 1986-07-22 Hoechst-Roussel Pharmaceuticals Inc. Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
EP0759299B1 (en) * 1995-08-16 2000-04-26 Eli Lilly And Company Potentiation of serotonin response
CN1206207C (en) 1997-07-08 2005-06-15 H.隆德贝克有限公司 Preparation method of cyanophthaofluoroaniline
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
SK283907B6 (en) 1997-11-11 2004-04-06 H. Lundbeck A/S A method for the preparation of citalopram
PL199423B1 (en) 1998-10-20 2008-09-30 Lundbeck & Co As H Method for the preparation of citalopram
KR20010081071A (en) 1998-12-08 2001-08-25 피터슨 존 메이달 Benzofuran derivatives, their preparation and use
AR021509A1 (en) * 1998-12-08 2002-07-24 Lundbeck & Co As H BENZOFURAN DERIVATIVES, ITS PREPARATION AND USE
JP2002533450A (en) 1998-12-23 2002-10-08 ハー・ルンドベック・アクチエゼルスカベット Method for producing 5-cyanophthalide
AR022329A1 (en) 1999-01-29 2002-09-04 Lundbeck & Co As H METHOD FOR THE PREPARATION OF 5-CYANOFTALIDE
HU227473B1 (en) * 1999-04-14 2011-07-28 Lundbeck & Co As H Method for preparation of citalopram
ITMI991581A1 (en) * 1999-06-25 2001-01-15 Lundbeck & Co As H METHOD FOR THE PREPARATION OF CITALOPRAM
ITMI991579A1 (en) * 1999-06-25 2001-01-15 Lundbeck & Co As H METHOD FOR THE PREPARATION OF CITALOPRAM
ITMI991486A1 (en) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A PROCESS FOR THE SYNTHESIS OF CITALOPRAM
AR021155A1 (en) * 1999-07-08 2002-06-12 Lundbeck & Co As H TREATMENT OF NEUROTIC DISORDERS
SK287139B6 (en) 1999-10-25 2010-01-07 H. Lundbeck A/S Method for the preparation of citalopram
SI1228056T1 (en) 1999-10-25 2005-02-28 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (en) 1999-11-01 2002-12-26 Lundbeck & Co As H METHOD FOR THE PREPARATION OF 5-CARBOXIFTALIDA.
US6310222B1 (en) * 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
MXPA02006503A (en) 1999-12-28 2002-12-09 Lundbeck & Co As H Method for the preparation of citalopram.
BR9917604A (en) * 1999-12-30 2002-12-31 Lundbeck & Co As H Method for preparing citalopram
ATE252570T1 (en) * 2000-01-14 2003-11-15 Lundbeck & Co As H METHOD FOR PRODUCING 5-CYANOPHTHALIDE
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
NL1017415C1 (en) * 2000-02-24 2001-05-18 Lundbeck & Co As H Process for the preparation of Citalopram.
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017417C1 (en) * 2000-03-03 2001-03-16 Lundbeck & Co As H Process for the preparation of Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
PL360110A1 (en) 2000-03-13 2004-09-06 H.Lundbeck A/S Method for the preparation of citalopram
NZ521204A (en) * 2000-03-13 2004-03-26 H Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)- 1,3-dihydroisobenzofurans for preparing citalopram, an anti depressant
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
EP1265882B1 (en) 2000-03-14 2004-01-14 H. Lundbeck A/S Method for the preparation of citalopram
TR200202168T2 (en) * 2000-03-16 2002-12-23 H. Lundbeck A/S Preparation method of 5-Cyano-1- (4-Fluorophenyl) -1,3-Dihydroisobenzofurans
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (en) * 2000-05-12 2003-11-12 Lundbeck & Co As H METHOD FOR THE PREPARATION OF CITALOPRAM, AN INTERMEDIARY EMPLOYED IN THE METHOD, A METHOD FOR THE PREPARATION OF THE INTERMEDIARY EMPLOYED IN THE METHOD AND PHARMACEUTICAL COMPOSITION ANTIDEPRESSIVE
KR100821912B1 (en) * 2000-05-12 2008-04-16 하. 룬트벡 아크티에 셀스카브 Process for producing citalopram
AU2001272368A1 (en) * 2000-07-06 2002-01-21 H. Lundbeck, A/S Method for the preparation of citalopram
CA2416447A1 (en) * 2000-07-21 2002-01-31 H. Lundbeck A/S Novel compounds and their use as glycine transport inhibitors
CA2353693C (en) 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
CA2354880C (en) * 2000-08-18 2003-06-03 H. Lundbeck A/S Method for the preparation of citalopram
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
IT1319686B1 (en) * 2000-12-12 2003-10-23 C D Farmasint S R L CITALOPRAM PREPARATION PROCEDURE.
ES2228824T3 (en) * 2000-12-22 2005-04-16 H. Lundbeck A/S PURE CITALOPRAM PREPARATION METHOD.
CA2359810C (en) * 2000-12-28 2002-11-05 H. Lundbeck A/S Process for the preparation of pure citalopram
DE10164725B4 (en) * 2000-12-28 2004-08-26 H. Lundbeck A/S Process for the preparation of purified citalopram
DE10112828C1 (en) * 2000-12-28 2002-11-21 Lundbeck & Co As H Preparation of high purity citalopram comprises a cyanide exchange reaction followed by thin film distillation and recrystallization from methanol and water
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
CA2435925A1 (en) * 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
JP2004529883A (en) * 2001-02-22 2004-09-30 ナトコ ファーマ リミテッド Preparation method of citalopram
GB0105627D0 (en) 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
WO2002072565A1 (en) * 2001-03-09 2002-09-19 Ranbaxy Laboratories Limited Process for the preparation of citalopram
MXPA03008777A (en) * 2001-05-01 2004-02-12 Lundbeck & Co As H The use of enantiomeric pure escitalopram.
BG65271B1 (en) * 2001-06-18 2007-11-30 H. Lundbeck A/S Method for the preparation of citalopram
AR034759A1 (en) * 2001-07-13 2004-03-17 Lundbeck & Co As H METHOD FOR THE PREPARATION OF ESCITALOPRAM
IN192057B (en) * 2001-07-19 2004-02-14 Ranbaxy Lab Ltd
DK1522539T3 (en) * 2001-07-31 2007-05-07 Lundbeck & Co As H Crystalline composition containing excitalopram
EP1288211A1 (en) * 2001-08-28 2003-03-05 Sekhsaria Chemicals Ltd. Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
NZ532033A (en) * 2001-10-12 2006-11-30 Azevan Pharmaceuticals Inc 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives as vasopressin V1a receptor antagonists
IN192863B (en) * 2001-11-13 2004-05-22 Ranbaxy Lab Ltd
IS7239A (en) * 2001-12-14 2004-04-29 H. Lundbeck A/S Process for the production of acitalopram
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB2387596B (en) * 2002-02-27 2004-02-11 Matrix Lab Ltd Process
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
WO2003080558A1 (en) * 2002-03-27 2003-10-02 Bando Chemical Industries, Ltd. Novel 1,3,5-tris(arylamino)benzene
CA2381341A1 (en) * 2002-04-09 2003-10-09 Torcan Chemical Ltd. Process and intermediates for preparing escitalopram
FI20021421A0 (en) * 2002-07-30 2002-07-30 Orion Corp Fermion Production Process
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
AU2002330730A1 (en) * 2002-08-14 2004-03-03 Natco Pharma Limited Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
GB2385051B (en) * 2002-08-29 2003-12-24 Max India Ltd Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ES2298595T3 (en) * 2002-12-23 2008-05-16 H. Lundbeck A/S ESCITALOPRAM HYDROBROMIDE AND A METHOD FOR PREPARATION.
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
WO2004065375A1 (en) * 2003-01-17 2004-08-05 Natco Pharma Limited Processes for the preparation of escitalopram and its precursor
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
ITMI20030479A1 (en) * 2003-03-13 2004-09-14 Adorkem Technology S P A PROCEDURE FOR THE PREPARATION OF A CYAN-ISOBENZOFURANO.
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
GB0317475D0 (en) * 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
ITFI20030202A1 (en) * 2003-07-28 2005-01-29 Synteco Spa PROCESS FOR THE PREPARATION OF DERIVATIVES DEL
SI1668014T1 (en) * 2003-09-17 2009-06-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
DE60300502T2 (en) * 2003-10-28 2006-02-23 Adorkem Technology S.P.A., Costa Volpino Process for the preparation of citalopram
WO2005042473A1 (en) * 2003-10-28 2005-05-12 Wockhardt Limited Improved process for the manufacture of citalopram hydrobromide
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
EP2272514A1 (en) * 2003-12-02 2011-01-12 PharmaNeuroBoost N.V. Use of low dose pipamperone and a second active compound in the treatment of neurodegenerative diseases
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CN100569765C (en) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 Citalopram intermediate crystalline base
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20080119662A1 (en) * 2004-02-16 2008-05-22 Jubilant Organosys Limted One Spot Synthesis of Citalopram from 5-Cyanophthalide
US20050196453A1 (en) * 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (en) * 2004-04-09 2004-07-09 Adorkem Technology Spa CHEMO-ENZYMATIC PROCEDURE FOR THE PREPARATION OF ESCITALOPRAM
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (en) * 2004-08-11 2008-06-10 Myriad Genetics Inc pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
KR101166280B1 (en) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 Process for preparation of citalopram and enantiomers
EP1868434A4 (en) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc Beta-lactamylalkanoic acids for treating premenstrual disorders
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
CN101203216A (en) * 2005-04-22 2008-06-18 惠氏公司 Dihydrobenzofuran derivatives and uses thereof
AU2006239920A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
MX2007013179A (en) * 2005-04-22 2008-01-16 Wyeth Corp Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3- dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride.
CN101203218A (en) * 2005-04-22 2008-06-18 惠氏公司 Benzofurylalkanamine derivatives and their use as 5-HT2C agonists
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
SG163588A1 (en) 2005-07-08 2010-08-30 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
PL1910346T3 (en) * 2005-07-19 2019-09-30 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
JP2009512711A (en) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Regulation of neurogenesis by PDE inhibition
JP2009513672A (en) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド GABA receptor-mediated regulation of neurogenesis
EP1951726A2 (en) * 2005-11-14 2008-08-06 H.Lundbeck A/S Method for the preparation of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
FR2912057B1 (en) * 2007-02-07 2009-04-17 Sanofi Aventis Sa PHARMACEUTICAL COMPOSITION COMPRISING SAREDUTANT AND A SELECTIVE SEROTONIN RECAPTURE INHIBITOR OR SEROTONIN / NOREPINEPHRINE RECAPTURE INHIBITOR
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
RU2008135326A (en) * 2006-03-24 2010-04-27 Вайет (Us) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DEPRESSION
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
MX2009002496A (en) * 2006-09-08 2009-07-10 Braincells Inc Combinations containing a 4-acylaminopyridine derivative.
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
JP4927497B2 (en) * 2006-10-25 2012-05-09 株式会社シスコ Moisture-free hopper equipment
CN100457747C (en) * 2006-11-21 2009-02-04 浙江大学 Preparation process of key intermediate 5-cyanophthalide of antidepressant citalopram
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
EP1988086B2 (en) 2007-04-23 2014-11-26 Synthon B.V. Process for resolving citalopram via its (S)-enriched citalopram tartrate compound.
US8288568B2 (en) * 2007-05-18 2012-10-16 Cipla Limited Process for the preparation of escitalopram
US20080312318A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched escitalopram
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
US8022232B2 (en) * 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
KR101103118B1 (en) * 2007-11-02 2012-01-04 동아제약주식회사 Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivative compound and pharmaceutical composition for treating premature ejaculation containing the same
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
EP2116231A1 (en) 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
US20100087664A1 (en) * 2008-10-07 2010-04-08 Ravindra Vedantham Preparation of citalopram and salts thereof
GR20080100696A (en) 2008-10-23 2010-05-13 Genepharm �.�. Taste masked dosage form of pharmaceutically aceptable salt of escitalopram
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
PT2491038T (en) 2009-10-23 2016-07-14 Janssen Pharmaceutica Nv Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
WO2012003436A1 (en) 2010-07-01 2012-01-05 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
WO2013081567A1 (en) 2011-12-02 2013-06-06 Mahmut Bilgic Effervescent antipsychotic formulations
WO2013100870A1 (en) 2011-12-02 2013-07-04 Mahmut Bilgic New antipsychotic compositions
WO2013110313A1 (en) * 2012-01-23 2013-08-01 H. Lundbeck A/S Selective allosteric modulators of the serotonin transporter
MX2021005502A (en) 2014-03-28 2023-01-16 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases.
KR102559922B1 (en) 2016-03-10 2023-07-25 얀센 파마슈티카 엔.브이. The remedial method of the depression using the orexin -2 receptor antagonist
BR112020005107A2 (en) 2017-09-15 2020-11-03 Azevan Pharmaceuticals, Inc. compositions and methods for the treatment of brain injury
KR20220049526A (en) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 Non-sedative dexmedetomidine treatment regimen
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (en) * 1965-03-18

Also Published As

Publication number Publication date
NO147243B (en) 1982-11-22
BE850401A (en) 1977-07-14
DK143275B (en) 1981-08-03
CH632259A5 (en) 1982-09-30
NO1996001I1 (en) 1996-01-05
CA1094087A (en) 1981-01-20
ZA7757B (en) 1977-11-30
NZ183001A (en) 1978-06-02
NO147243C (en) 1983-03-02
AU2107377A (en) 1978-07-13
DE2657013A1 (en) 1977-07-28
AT359488B (en) 1980-11-10
FI63754C (en) 1983-08-10
NL7700244A (en) 1977-07-18
CH626886A5 (en) 1981-12-15
IE44055L (en) 1977-07-14
CH632258A5 (en) 1982-09-30
US4136193A (en) 1979-01-23
FR2338271A1 (en) 1977-08-12
NL192451C (en) 1997-08-04
NO770109L (en) 1977-07-15
FR2338271B1 (en) 1982-11-05
NL192451B (en) 1997-04-01
NL970031I1 (en) 1997-10-01
DK143275C (en) 1982-01-18
GB1526331A (en) 1978-09-27
DK13177A (en) 1977-07-15
DE2657013C2 (en) 1985-11-14
JPS6135986B2 (en) 1986-08-15
AU509445B2 (en) 1980-05-15
IE44055B1 (en) 1981-07-29
JPS52105162A (en) 1977-09-03
FI770073A7 (en) 1977-07-15
SE7614201L (en) 1977-07-15
FI63754B (en) 1983-04-29
ATA947276A (en) 1980-04-15
ES454980A1 (en) 1978-04-01
SE429551B (en) 1983-09-12

Similar Documents

Publication Publication Date Title
NL970031I2 (en) Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.
NL7903421A (en) N-SUBSTITUTED MORANOLINE DERIVATIVES, METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT THEREOF, AND THE MEDICINAL PRODUCT THEREOF.
NL190812C (en) Process for the preparation of 1,4-dihydropyridine derivatives with vasodilating and hypotensive effects, and pharmaceutical preparations comprising these derivatives.
NL7614470A (en) PROCESS FOR THE PREPARATION OF A STABLE ANTI-BIOTIC PREPARATION AND FORMED PREPARATIONS CONTAINING THIS PREPARATION.
NL7507441A (en) METHOD OF PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
NL7604016A (en) PROCEDURE FOR PREPARING PROSTAGLANDIN DERIVATIVES AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT CONTAINING PROSTAGLANDIN ACTION.
NL7604583A (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOLE DERIVASES AND PREPARATIONS CONTAINING THEM.
NL7611085A (en) PROCESS FOR THE PREPARATION OF NEUROLEPTIC ACTING SUBSTANCES AND OF PREPARATIONS CONTAINING THEY.
NL184467C (en) 6-OXO-PROSTAGLANDIN EŸ1 DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NL165463C (en) PROCESS FOR THE PREPARATION OF FUNGICIDE IMIDAZOLYL DERIVATIVES AND FOR THE PREPARATION OF PREPARATIONS CONTAINING THEM.
NL7514255A (en) PROCESS FOR THE PREPARATION OF PIPERIDYLINDOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEY.
NL7601114A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL7512902A (en) PROCESS FOR THE PREPARATION OF HERBICIDE SUBSTANCES AND OF PREPARATIONS CONTAINING THEY.
NL7703237A (en) METHOD FOR THE PREPARATION OF A VETERINARY MEDICINAL PRODUCT.
NL7707684A (en) PROCESS FOR THE PREPARATION OF HYPOLYPEMIC SUBSTANCES AND PREPARATIONS CONTAINING THEM.
NL7613206A (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL7704542A (en) PROCEDURE FOR PREPARING ISOTHIAZOLOPYRIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND.
NL7712996A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL7708162A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL7714205A (en) PROCESS FOR THE PREPARATION OF 5-FLUORURACILDERISMS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES.
NL7703236A (en) METHOD FOR THE PREPARATION OF A VETERINARY MEDICINAL PRODUCT.
NL7700899A (en) PROCESS FOR THE PREPARATION OF COCCIDIOSTATICS AND OF PREPARATIONS CONTAINING THEY.
NL7614190A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL179053C (en) N-SUBSTITUTED MORANOLINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH DERIVATIVE THEREIN.
NL7601423A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.